Process View
Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte activation.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of leukocyte activation"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
B2M | beta-2-microglobulin | 0.965 | ||
HLA-C | major histocompatibility complex, class I, C | 0.964 | Human | |
HLA-B | major histocompatibility complex, class I, B | 0.949 | ||
CD80 | CD80 molecule | 0.929 | ||
HLA-A | major histocompatibility complex, class I, A | 0.875 | Human | |
PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.825 | ||
HLA-G | major histocompatibility complex, class I, G | 0.793 | ||
HLA-E | major histocompatibility complex, class I, E | 0.785 | Human | |
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.746 | Mouse | |
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.698 | Mouse | |
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.611 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.477 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.470 | ||
HLA-F | major histocompatibility complex, class I, F | 0.419 | Human | |
LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.396 | ||
LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.373 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.319 | ||
INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.299 | Mouse | |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.259 | Human | |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.230 | ||
CD86 | CD86 molecule | 0.226 | ||
PILRA | paired immunoglobin-like type 2 receptor alpha | 0.210 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.199 | ||
FSTL1 | follistatin-like 1 | 0.193 | ||
IL2RG | interleukin 2 receptor, gamma | 0.188 | ||
IL4R | interleukin 4 receptor | 0.174 | Mouse | |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.172 | ||
UBC | ubiquitin C | 0.168 | ||
BTN3A3 | butyrophilin, subfamily 3, member A3 | 0.167 | ||
IL10 | interleukin 10 | 0.157 | ||
POU5F1 | POU class 5 homeobox 1 | 0.148 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.143 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.138 | ||
BLNK | B-cell linker | 0.133 | ||
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.131 | ||
DRD2 | dopamine receptor D2 | 0.125 | ||
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.123 | ||
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.122 | Mouse | |
CCL4 | chemokine (C-C motif) ligand 4 | 0.119 | Human | |
CD33 | CD33 molecule | 0.117 | ||
LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.116 | ||
LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.106 | Human | |
CCL13 | chemokine (C-C motif) ligand 13 | 0.106 | Human | |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.106 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.105 | Human | |
UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.104 | ||
RNF11 | ring finger protein 11 | 0.103 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.102 | ||
PAX3 | paired box 3 | 0.094 | ||
SYK | spleen tyrosine kinase | 0.091 | ||
POU3F2 | POU class 3 homeobox 2 | 0.088 | ||
GAS6 | growth arrest-specific 6 | 0.086 | ||
IL10RA | interleukin 10 receptor, alpha | 0.083 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.081 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.081 | ||
SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.080 | ||
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.080 | ||
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.079 | ||
EPOR | erythropoietin receptor | 0.079 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.078 | ||
TRAF6 | TNF receptor-associated factor 6 | 0.075 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.072 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.071 | ||
TFF1 | trefoil factor 1 | 0.065 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.063 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.063 | ||
IL2RA | interleukin 2 receptor, alpha | 0.061 | Mouse | |
ICAM1 | intercellular adhesion molecule 1 | 0.060 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.058 | Human | |
NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.058 | ||
LAT | linker for activation of T cells | 0.058 | ||
XIAP | X-linked inhibitor of apoptosis | 0.058 | ||
APAF1 | apoptotic peptidase activating factor 1 | 0.057 | ||
HK3 | hexokinase 3 (white cell) | 0.056 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.056 | Human | |
GHR | growth hormone receptor | 0.054 | ||
IL22RA1 | interleukin 22 receptor, alpha 1 | 0.053 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.051 | Human | |
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.051 | ||
CD163 | CD163 molecule | 0.048 | ||
TAPBP | TAP binding protein (tapasin) | 0.048 | ||
WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.047 | ||
PINK1 | PTEN induced putative kinase 1 | 0.047 | ||
LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.047 | ||
CSK | c-src tyrosine kinase | 0.046 | ||
ADAM17 | ADAM metallopeptidase domain 17 | 0.045 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.045 | ||
NLRP3 | NLR family, pyrin domain containing 3 | 0.043 | ||
IL4 | interleukin 4 | 0.042 | Mouse | |
CCR4 | chemokine (C-C motif) receptor 4 | 0.042 | ||
FPR3 | formyl peptide receptor 3 | 0.042 | ||
MICA | MHC class I polypeptide-related sequence A | 0.042 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.042 | Human | |
CCL22 | chemokine (C-C motif) ligand 22 | 0.041 | Human | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.041 | ||
TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.041 | ||
HCK | hemopoietic cell kinase | 0.040 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.040 | ||
TNF | tumor necrosis factor | 0.039 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.038 | ||
IDE | insulin-degrading enzyme | 0.038 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.038 | ||
IL22RA2 | interleukin 22 receptor, alpha 2 | 0.038 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.038 | ||
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.037 | ||
HDAC9 | histone deacetylase 9 | 0.036 | ||
FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.036 | ||
IFNG | interferon, gamma | 0.035 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.035 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.035 | ||
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.032 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.032 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.032 | ||
C19orf50 | chromosome 19 open reading frame 50 | 0.032 | ||
LAPTM5 | lysosomal protein transmembrane 5 | 0.031 | ||
LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.031 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.030 | ||
CD28 | CD28 molecule | 0.030 | Human | |
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.030 | ||
LCK | lymphocyte-specific protein tyrosine kinase | 0.030 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.027 | ||
UBD | ubiquitin D | 0.027 | ||
IRF9 | interferon regulatory factor 9 | 0.026 | ||
CD14 | CD14 molecule | 0.026 | ||
CD83 | CD83 molecule | 0.026 | ||
GRAP2 | GRB2-related adaptor protein 2 | 0.026 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.026 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.025 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.025 | ||
CMKLR1 | chemokine-like receptor 1 | 0.025 | ||
SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.024 | ||
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.024 | ||
PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.024 | ||
CD300A | CD300a molecule | 0.024 | ||
IL15RA | interleukin 15 receptor, alpha | 0.024 | ||
LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.023 | Human | |
PLEK | pleckstrin | 0.023 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.023 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.023 | Human | |
PSAP | prosaposin | 0.022 | ||
PLK3 | polo-like kinase 3 | 0.022 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.022 | ||
STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.022 | ||
APP | amyloid beta (A4) precursor protein | 0.022 | ||
MARCO | macrophage receptor with collagenous structure | 0.022 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.021 | ||
SLAMF7 | SLAM family member 7 | 0.020 | ||
SMAD7 | SMAD family member 7 | 0.020 | ||
CH25H | cholesterol 25-hydroxylase | 0.020 | ||
BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.020 | ||
PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.020 | ||
MSR1 | macrophage scavenger receptor 1 | 0.020 | ||
THOC5 | THO complex 5 | 0.020 | ||
SIRPA | signal-regulatory protein alpha | 0.020 | ||
NMI | N-myc (and STAT) interactor | 0.020 | ||
ATMIN | ATM interactor | 0.020 | ||
THAP2 | THAP domain containing, apoptosis associated protein 2 | 0.020 | ||
MAN2B1 | mannosidase, alpha, class 2B, member 1 | 0.020 | ||
SLA | Src-like-adaptor | 0.020 | ||
MEOX2 | mesenchyme homeobox 2 | 0.019 | ||
DOK3 | docking protein 3 | 0.019 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.019 | ||
GAB2 | GRB2-associated binding protein 2 | 0.019 | ||
UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.019 | ||
SNX18 | sorting nexin 18 | 0.019 | ||
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.019 | ||
GBP4 | guanylate binding protein 4 | 0.019 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.018 | ||
CD274 | CD274 molecule | 0.018 | Mouse | |
IRF4 | interferon regulatory factor 4 | 0.018 | ||
PBK | PDZ binding kinase | 0.018 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.018 | Human | |
BCL2A1 | BCL2-related protein A1 | 0.018 | ||
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.018 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.018 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.017 | ||
PECAM1 | platelet/endothelial cell adhesion molecule | 0.017 | ||
GAB1 | GRB2-associated binding protein 1 | 0.017 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.017 | ||
FTL | ferritin, light polypeptide | 0.017 | ||
IL18RAP | interleukin 18 receptor accessory protein | 0.017 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.017 | ||
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.017 | Human Rat | |
CD72 | CD72 molecule | 0.017 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.017 | ||
MSTO1 | misato homolog 1 (Drosophila) | 0.016 | ||
IL1B | interleukin 1, beta | 0.016 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.016 | ||
APBA3 | amyloid beta (A4) precursor protein-binding, family A, member 3 | 0.016 | ||
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.016 | Human | |
TYMP | thymidine phosphorylase | 0.016 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.016 | ||
BMP2 | bone morphogenetic protein 2 | 0.016 | Human | |
ADAMDEC1 | ADAM-like, decysin 1 | 0.016 | ||
SIRPB1 | signal-regulatory protein beta 1 | 0.015 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.015 | ||
CDK6 | cyclin-dependent kinase 6 | 0.015 | ||
SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.015 | ||
ZBTB48 | zinc finger and BTB domain containing 48 | 0.015 | ||
RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.015 | ||
MARCKSL1 | MARCKS-like 1 | 0.015 | ||
IRF8 | interferon regulatory factor 8 | 0.015 | ||
JAK2 | Janus kinase 2 | 0.015 | ||
APOE | apolipoprotein E | 0.015 | ||
ICOS | inducible T-cell co-stimulator | 0.014 | ||
SELE | selectin E | 0.014 | ||
CHIT1 | chitinase 1 (chitotriosidase) | 0.014 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.014 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.014 | ||
SCNM1 | sodium channel modifier 1 | 0.014 | ||
ZNF282 | zinc finger protein 282 | 0.014 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.014 | ||
SNAP23 | synaptosomal-associated protein, 23kDa | 0.014 | ||
ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 0.014 | ||
SNX9 | sorting nexin 9 | 0.014 | ||
AOAH | acyloxyacyl hydrolase (neutrophil) | 0.013 | ||
PTAFR | platelet-activating factor receptor | 0.013 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.013 | ||
SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.013 | ||
BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.013 | Mouse | |
CD69 | CD69 molecule | 0.013 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.013 | ||
SLAMF8 | SLAM family member 8 | 0.013 | ||
IFNB1 | interferon, beta 1, fibroblast | 0.013 | ||
CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.013 | ||
IL13 | interleukin 13 | 0.013 | ||
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.013 | ||
PPAP2B | phosphatidic acid phosphatase type 2B | 0.012 | ||
TFEC | transcription factor EC | 0.012 | ||
PCDH9 | protocadherin 9 | 0.012 | ||
MAPK3 | mitogen-activated protein kinase 3 | 0.012 | ||
LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.012 | Human | |
TAPBPL | TAP binding protein-like | 0.012 | ||
TP73 | tumor protein p73 | 0.012 | ||
HDAC5 | histone deacetylase 5 | 0.012 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.012 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.012 | ||
SRGN | serglycin | 0.012 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.012 | ||
CLEC10A | C-type lectin domain family 10, member A | 0.012 | ||
ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.012 | ||
OPTN | optineurin | 0.012 | ||
APOC1 | apolipoprotein C-I | 0.012 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.012 | ||
GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.012 | ||
PRDM1 | PR domain containing 1, with ZNF domain | 0.012 | Mouse | |
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.012 | ||
MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.012 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.012 | ||
IGSF6 | immunoglobulin superfamily, member 6 | 0.011 | ||
IRF5 | interferon regulatory factor 5 | 0.011 | ||
CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.011 | ||
PDCD1LG2 | programmed cell death 1 ligand 2 | 0.011 | Mouse | |
C2 | complement component 2 | 0.011 | ||
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.011 | ||
CD320 | CD320 molecule | 0.011 | ||
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.011 | ||
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.011 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.011 | ||
IL2RB | interleukin 2 receptor, beta | 0.011 | ||
MAP4K3 | mitogen-activated protein kinase kinase kinase kinase 3 | 0.011 | ||
CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.011 | ||
TFG | TRK-fused gene | 0.011 | ||
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.011 | ||
TYROBP | TYRO protein tyrosine kinase binding protein | 0.011 | ||
CD1B | CD1b molecule | 0.011 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.011 | ||
PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.011 | ||
CCL21 | chemokine (C-C motif) ligand 21 | 0.011 | ||
TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.011 | ||
FPR2 | formyl peptide receptor 2 | 0.011 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.011 | ||
SIGLEC10 | sialic acid binding Ig-like lectin 10 | 0.011 | ||
CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.011 | ||
SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.011 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.010 | ||
C3AR1 | complement component 3a receptor 1 | 0.010 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.010 | ||
DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.010 | ||
RNF111 | ring finger protein 111 | 0.010 | ||
CCNL1 | cyclin L1 | 0.010 | ||
PLUNC | palate, lung and nasal epithelium associated | 0.010 | ||
STK36 | serine/threonine kinase 36 | 0.010 | ||
CD247 | CD247 molecule | 0.010 | ||
IL1RN | interleukin 1 receptor antagonist | 0.010 | ||
GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.010 | ||
S100A12 | S100 calcium binding protein A12 | 0.010 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.010 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.010 |